Ask AI
ProCE Banner Activity

CE / CME

Turning Down the Heat in Hidradenitis Suppurativa: Translating Emerging Mechanistic Insights and Biologic Innovation Into Meaningful Patient Outcomes

Video

Understanding how to recognize hidradenitis suppurativa (HS) across diverse skin tones and phenotypes can shorten diagnostic delays and prevent irreversible tissue damage. Watch this on-demand webcast to learn about emerging mechanistic insights in HS, best practices for disease staging, and the latest data on biologic therapies, including how to translate these insights into practical treatment pathways to bring individualized care and shared decision-making strategies to patients with HS.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Released: September 08, 2026

Expiration: September 07, 2027

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with HS Foundation and Integrative Dermatology Symposium/LearnSkin.

ProCE Banner

Supporters

Supported by an educational grant from Incyte Corporation.

Incyte Corporation

Partners

HS Foundation

ProCE Banner

Integrative Dermatology Symposium/LearnSkin

ProCE Banner

Target Audience

This activity is intended for dermatologists, nurse practitioners, physician associates, and other HCPs who care for people living with hidradenitis suppurativa.

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Hidradenitis Suppurativa.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Implement structured diagnostic and staging frameworks to reduce time-to-diagnosis and mitigate irreversible tissue damage in patients with HS

  • Individualize advanced therapeutic strategies by integrating efficacy benchmarks, safety considerations, and patient-reported outcomes into shared decision-making discussions

  • Operationalize comprehensive, patient-centered care models that integrate dermatology, surgery, pain management, and behavioral health to address the full burden of HS

Financial Disclosures

Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Steve Daveluy, MD, FAAD: consultant/advisor/speaker: AbbVie, Incyte, Leo, Novartis, UCB; researcher: AbbVie, Incyte, Insmed, Leo, MoonLake, Novartis, Pfizer, Regeneron, Sanofi, Takeda, UCB.

Mark Dixon, MBA, MS: consultant/advisor/speaker: Incyte, Oruka.

Venessa Peña-Robichaux, MD: stock/advisor: Osquo.

The planners and content peer reviewers from Decera Clinical Education and the HS Foundation do not have any relevant financial relationships to disclose.​



Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from September 08, 2026, through September 07, 2027:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Additional Disclosures

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Generative artificial intelligence (AI) tools were used for generating clinical case scenarios. All AI-assisted content underwent human review, editing, and validation by qualified faculty and accredited education staff to ensure scientific accuracy, balance, and compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education.​

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC dba Decera Clinical Education and the HS Foundation. Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.

Physician Associate Continuing Medical Education 

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until September 07, 2027. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation

A logo for a credit companyAI-generated content may be incorrect.

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.